Results 311 to 320 of about 181,705 (382)

Cystatin C as Biomarker for the Evaluation of Renal Outcome in AL Amyloidosis

open access: yesAmerican Journal of Hematology, Volume 100, Issue 8, Page 1305-1313, August 2025.
ABSTRACT Cystatin C (CysC) has emerged as a novel and potentially more reliable biomarker for the estimation of glomerular filtration in the general population in patients with various conditions. In AL amyloidosis, the current renal staging system and renal response criteria are based on proteinuria and creatinine‐based eGFR.
Foteini Theodorakakou   +18 more
wiley   +1 more source

Subtle Alterations in Hippocampal Neuronal Activity Coincide With Early Sex‐Specific Differences in Amyloidosis and Microglia in a Pre‐Symptomatic Mouse Model of Alzheimer‐Like Pathology

open access: yesGlia, Volume 73, Issue 8, Page 1727-1745, August 2025.
Main Points In a pre‐symptomatic mouse model of Alzheimer disease, despite higher amyloid‐β load females display less plaques than males. More efficient synaptic transmission as well as less microgliosis point to better early coping with pathogenesis in females.
Thomas Chaigneau   +7 more
wiley   +1 more source

Prevalence of cardiac fibrosis and infiltrative cardiomyopathy in patients with advanced conduction system disease

open access: yesJournal of Arrhythmia, Volume 41, Issue 4, August 2025.
Prevalence of cardiac fibrosis and sarcoidosis in patients with advanced conduction system disease. Abstract Background Conduction system disease may represent an early manifestation of underlying structural heart disease, including infiltrative disorders.
Jeremy William   +12 more
wiley   +1 more source

Case Series: Genetic mimics of hypertrophic cardiomyopathy in elderly. [PDF]

open access: yesFront Cardiovasc Med
Chumakova OS   +5 more
europepmc   +1 more source

Microglial Drivers of Alzheimer's Disease Pathology: An Evolution of Diverse Participating States

open access: yesProteins: Structure, Function, and Bioinformatics, Volume 93, Issue 8, Page 1330-1348, August 2025.
ABSTRACT Microglia, the resident immune‐competent cells of the brain, become dysfunctional in Alzheimer's disease (AD), and their aberrant immune responses contribute to the accumulation of pathological proteins and neuronal injury. Genetic studies implicate microglia in the development of AD, prompting interest in developing immunomodulatory therapies
Madison K. Kuhn, Elizabeth A. Proctor
wiley   +1 more source

Home - About - Disclaimer - Privacy